Article Text

Download PDFPDF

Selenium supplementation and insulin resistance in a randomized, clinical trial
  1. Elizabeth Theresa Jacobs1,2,3,
  2. Peter Lance2,4,
  3. Lawrence J Mandarino4,5,
  4. Nathan A Ellis2,
  5. H-H Sherry Chow2,
  6. Janet Foote1,
  7. Jessica A Martinez2,3,
  8. Chiu-Hsieh Paul Hsu1,2,
  9. Ken Batai6,
  10. Kathylynn Saboda2,
  11. Patricia A Thompson7
  1. 1 Department of Epidemiology and Biostatistics, Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, Arizona
  2. 2 University of Arizona Cancer Center, Tucson, Arizona
  3. 3 Department of Nutritional Sciences, University of Arizona, Tucson, Arizona
  4. 4 Department of Medicine, University of Arizona, Tucson, Arizona
  5. 5 Center for Disparities in Diabetes, Obesity and Metabolism, University of Arizona, Tucson, Arizona
  6. 6 Department of Surgery, University of Arizona, Tucson, Arizona
  7. 7 Department of Medicine, Stony Brook University, New York City, New York, USA
  1. Correspondence to Dr Elizabeth Theresa Jacobs; jacobse{at}email.arizona.edu

Footnotes

  • ETJ and PL contributed equally.

  • Contributors ETJ, PL, LJM, H-HSC, and ETJ were responsible for the initial design of the project, as well as data collection. C-HPH, ETJ, and KS were responsible for conducting the data analyses. NAE, JF, JAM, C-HPH, and KB made key contributions to the preparation of the manuscript, specifically in interpretation of the data. All authors participated in the writing of the manuscript and have approved it in its final form for submission.

  • Funding Financial Support: the National Cancer Institute Cancer Center Support Grant P30 CA023074, NIH/NCI R01CA151708 (ETJ), NIH/NCI P01 CA041108 (PL); NIH R01DK047396 (LJM) and NIH/NCI R01CA151708 (PL).

  • Competing Interests None declared.

  • Patient consent for publication Not required.

  • Ethics approval The University of Arizona Institutional Review Board (IRB) approved and oversaw the study protocol.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Data sharing statement Data requests should be directed to ETJ at jacobse@email.arizona.edu. Deidentified data included in this work may be obtained through an established process. A data request form will be supplied for completion and approval by the authors the manuscript. Reuse is permitted for reasonable, scientifically rigorous research.

View Full Text

Statistics from Altmetric.com

Footnotes

  • ETJ and PL contributed equally.

  • Contributors ETJ, PL, LJM, H-HSC, and ETJ were responsible for the initial design of the project, as well as data collection. C-HPH, ETJ, and KS were responsible for conducting the data analyses. NAE, JF, JAM, C-HPH, and KB made key contributions to the preparation of the manuscript, specifically in interpretation of the data. All authors participated in the writing of the manuscript and have approved it in its final form for submission.

  • Funding Financial Support: the National Cancer Institute Cancer Center Support Grant P30 CA023074, NIH/NCI R01CA151708 (ETJ), NIH/NCI P01 CA041108 (PL); NIH R01DK047396 (LJM) and NIH/NCI R01CA151708 (PL).

  • Competing Interests None declared.

  • Patient consent for publication Not required.

  • Ethics approval The University of Arizona Institutional Review Board (IRB) approved and oversaw the study protocol.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Data sharing statement Data requests should be directed to ETJ at jacobse@email.arizona.edu. Deidentified data included in this work may be obtained through an established process. A data request form will be supplied for completion and approval by the authors the manuscript. Reuse is permitted for reasonable, scientifically rigorous research.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.